GABA, a Neurotransmitter, and Glycine, a Inhibitory neurotransmitter, NMDA co-agonist, Sleep aid, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. GABA is classified as a Neurotransmitter while Glycine is a Inhibitory neurotransmitter, NMDA co-agonist, Sleep aid, meaning they approach altered states through different pharmacological mechanisms. They share 0 documented effects in common, with 11 effects unique to GABA and 2 unique to Glycine. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| Level | GABA | Glycine |
|---|---|---|
| Threshold | 60 mg | 600 mg |
| Light | 100–250 mg | 1000–2000 mg |
| Common | 250–750 mg | 3000–5000 mg |
| Strong | 750–1500 mg | 5000–10000 mg |
| Heavy | 3000 mg | 15000 mg |
GABA
Glycine
No direct interaction data available between these substances. This does not mean the combination is safe.
No dangerous interactions recorded.
No dangerous interactions recorded.